INVESTOR ALERT: Investigation of Universal American Corp. Announced by Glancy Binkow & Goldberg LLP

LOS ANGELES--(BUSINESS WIRE)--

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Universal American Corp. ("UAM" or the "Company") UAM concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by UAM between February 16, 2012 and November 7, 2013, concerning the Company's business and financial performance.

Please contact us at (310) 201-9150, or at shareholders@glancylaw.com to discuss this matter. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

UAM is a New York-based specialty health and life insurance holding company, which provides health insurance and managed care products and services to Medicare and Medicaid recipients in the United States. The investigation is related to UAM's November 7, 2013, announcement of the Company's financial results for the quarter ended September 30, 2013. For third quarter 2013 the Company reported a $7 million adjusted net loss for the quarter, or $0.08 per share, citing among other things “medical benefit ratios in our non-core markets [that] negatively impacted our results.”

If you purchased UAM securities between February 16, 2012 and November 7, 2013, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, at (646) 539-8980, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.